Skip to main content

Table 2 Summary of the effects of SNPs identified by eGWAS and ASE, and their relative proportions in the larger population of a given SNP category (%)

From: Deciphering the genetic regulation of peripheral blood transcriptome in pigs through expression genome-wide association study and allele-specific expression analysis

SNP effects

eGWAS

ASE

QC-SNPsa

eQTL-SNPs

P-valuesb

ASE-SNPs

3’UTR variant

274 (0.65%)

47 (1.47%)

1.71 × 10−6*

560 (24.5%)

5’UTR variant

51 (0.12%)

5 (0.16%)

5.95 × 10−1

51 (2.2%)

Downstream gene variant

1278 (3%)

150 (4.7%)

9.03 × 10−7*

125 (5.5%)

Intergenic variant

27,211 (64.7%)

1606 (50.5%)

4 × 10−56*

150 (6.6%)

Intronic variant

10,893 (25.9%)

1083 (34%)

1.4 × 10−22*

209 (9.1%)

Missense variant

187 (0.44%)

28 (0.87%)

1.79 × 10−3*

539 (23.6%)

Non-coding exon variant

18 (0.04%)

3 (0.09%)

1.80 × 10−1

127 (5.6%)

Splice region variant

68 (0.16%)

7 (0.21%)

3.70 × 10−1

14 (0.6%)

Stop lost

7 (0.016%)

1 (0.03%)

4.42 × 10−1

5 (0.2%)

Stop retained variant

16 (0.038%)

4 (0.13%)

4.78 × 10−2*

1 (0.04%)

Synonymous variant

553 (1.31%)

68 (1.19%)

3.45 × 10−4*

414 (18.1%)

Upstream gene variant

1526 (3.63%)

182 (5.7%)

1.92 × 10−8*

51 (2.2%)

Mature miRNA variant

1 (0.002%)

0

 

1 (0.04%)

Splice acceptor variant

1 (0.002%)

0

 

10 (0.4%)

Stop gained

5 (0.012%)

0

 

17 (0.7%)

Splice donor variant

   

12 (0.5%)

  1. aSNPs that met QC criteria
  2. b P-values for a Fisher test. For P < 0.05, the proportion of the SNP effect is significantly different between that of SNPs that passed the QC and that of eQTL-SNPs. Significant differences are labeled by a *